WO2009048274A3 - Benzofuran and benzothiophene derivatives substituted with amide, process for the preparation thereof, and pharmaceutical compositions containing the same - Google Patents
Benzofuran and benzothiophene derivatives substituted with amide, process for the preparation thereof, and pharmaceutical compositions containing the same Download PDFInfo
- Publication number
- WO2009048274A3 WO2009048274A3 PCT/KR2008/005933 KR2008005933W WO2009048274A3 WO 2009048274 A3 WO2009048274 A3 WO 2009048274A3 KR 2008005933 W KR2008005933 W KR 2008005933W WO 2009048274 A3 WO2009048274 A3 WO 2009048274A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amide
- benzofuran
- ischemic
- disease
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a novel benzofuran or benzothiophene derivative substituted with amide. The inventive benzofuran or benzothiophene derivative substituted with amide effectively inhibits ischemic cell death, and thus, can be advantageously used for preventing and treating ischemic diseases such as brain ischemia, heart ischemia, diabetic cardiovascular disease, heart failure, myocardial hypertrophy, retinal ischemia, ischemic colitis, ischemic acute renal failure, stroke, head trauma, Alzheimer's disease, Parkinson's disease, neonatal hypoxia, glaucoma, and diabetic neuropathy.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070103244A KR100937134B1 (en) | 2007-10-12 | 2007-10-12 | Benzofuran and bezothiophene derivatives substituted by amide, process for the preparation thereof, and pharmaceutical compositions containing the same |
KR10-2007-0103244 | 2007-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009048274A2 WO2009048274A2 (en) | 2009-04-16 |
WO2009048274A3 true WO2009048274A3 (en) | 2010-07-01 |
Family
ID=40549745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2008/005933 WO2009048274A2 (en) | 2007-10-12 | 2008-10-09 | Benzofuran and benzothiophene derivatives substituted with amide, process for the preparation thereof, and pharmaceutical compositions containing the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100937134B1 (en) |
WO (1) | WO2009048274A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101292836B1 (en) * | 2011-03-28 | 2013-08-05 | 한국화학연구원 | Pharmaceutical composition comprising benzofuran or benzothiophene derivatives and pharmaceutically acceptable salt thereof for prevention or treatment of spinal cord injury |
CN116410207A (en) * | 2019-05-09 | 2023-07-11 | 杭州普济远成生物医药科技有限公司 | Ubiquitin specific protease inhibitor and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005126374A (en) * | 2003-10-24 | 2005-05-19 | Kissei Pharmaceut Co Ltd | New adenosine a2a receptor antagonist |
JP2007056004A (en) * | 2005-07-26 | 2007-03-08 | Kissei Pharmaceut Co Ltd | New furopyridine derivative, pharmaceutical composition containing the same and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2553084A1 (en) | 2004-01-28 | 2005-08-11 | Kissei Pharmaceutical Co., Ltd. | Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
-
2007
- 2007-10-12 KR KR1020070103244A patent/KR100937134B1/en not_active IP Right Cessation
-
2008
- 2008-10-09 WO PCT/KR2008/005933 patent/WO2009048274A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005126374A (en) * | 2003-10-24 | 2005-05-19 | Kissei Pharmaceut Co Ltd | New adenosine a2a receptor antagonist |
JP2007056004A (en) * | 2005-07-26 | 2007-03-08 | Kissei Pharmaceut Co Ltd | New furopyridine derivative, pharmaceutical composition containing the same and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR100937134B1 (en) | 2010-01-15 |
KR20090037744A (en) | 2009-04-16 |
WO2009048274A2 (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008125945A3 (en) | 3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c | |
WO2011119663A8 (en) | Chemical compounds | |
PH12015501116A1 (en) | New indanyloxydihydrobenzofuranylacetic acids | |
WO2009049845A3 (en) | Bisamide derivatives and their use as insecticidal compounds | |
WO2009102155A3 (en) | Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds | |
EA201001733A1 (en) | DERIVATIVES OF THYENOPYRIDONE AS AMP-ACTIVATED PROTEINKINASE (AMRC) ACTIVATORS | |
WO2010077101A3 (en) | Novel thiazolidinedione derivative and use thereof | |
WO2008010238A3 (en) | Antidiabetic azabicyclo [3. 1. 0] hexan compounds | |
PH12014502141A1 (en) | New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists | |
WO2008131860A3 (en) | Pyridonecarboxamides crop protection agents containing the same method for production and use thereof | |
WO2012122340A8 (en) | Soluble guanylate cyclase activators | |
TW200738280A (en) | Novel pharmaceutical compositions comprising levetiracetam and process for their preparation | |
WO2009067493A3 (en) | 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders | |
WO2009100936A3 (en) | Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds, and the use thereof | |
WO2008080891A3 (en) | Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments | |
PH12014502802A1 (en) | Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient | |
WO2010006184A3 (en) | Small-molecule inhibitors of hif and angiogenesis | |
WO2009048274A3 (en) | Benzofuran and benzothiophene derivatives substituted with amide, process for the preparation thereof, and pharmaceutical compositions containing the same | |
WO2012030106A3 (en) | Production method of intermediate compound for synthesizing medicament | |
WO2010116079A9 (en) | Method for making up eyelashes | |
WO2012020991A3 (en) | Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients | |
WO2007121479A3 (en) | Methods and compositions for treating barth syndrome, cardiomyopathy, mitochondrial diseases and other conditions | |
WO2010019911A3 (en) | 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions | |
WO2006131338A3 (en) | Crystalline solvate of omeprazole sodium | |
WO2007109786A3 (en) | Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08837804 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
122 | Ep: pct application non-entry in european phase |
Ref document number: 08837804 Country of ref document: EP Kind code of ref document: A2 |